The Food and Drug Administration has approved Varithena (polidocanol injectable foam, BTG International) for the treatment of varicose veins.
Sarah Thuerk
Advertisement
Articles by Sarah Thuerk
A brief, online skin cancer course improved the diagnostic skills of primary care physicians, without impacting dermatology referrals, a recent study suggests.
The Food and Drug Administration has approved the topical acne drug Epiduo (adapalene 01. percent/benzoyl peroxide 2.5 percent, Galderma) in children ages 9 and older, according to a news release.
A microneedle radiofrequency (RF) device was as effective for acne vulgaris as a carbon dioxide (CO2) laser, but with less downtime, according to findings from a recent study.
Advertisement
Latest Updated Articles
- Microneedle RF device improves acne
Published: January 28th 2013 | Updated:
- Epiduo approved for children ages 9 and up
Published: February 19th 2013 | Updated:
- Online skin cancer course improves docs’ diagnostic skills
Published: November 12th 2013 | Updated:
- FDA approves injectable foam for varicose veins
Published: November 26th 2013 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
